Generation Bio

NASDAQ:  GBIO

Size:  $125mm

Bookrunners:  J.P. Morgan | Jefferies | Cowen

Major Holders:  Atlas Venture Fund | Fidelity | T. Rowe Price | Invus Public Equities

Description:  Generation Bio is an innovative genetic medicines company creating a new class of gene therapy utilizing their proprietary non-viral gene therapy platform to provide durable, redosable treatments for millions of patients living with rare and prevalent diseases.

Reference Link:  S-1